Tris trial is registered with FDA with number: NCT03015909. The sponsor of the trial is LG Life Sciences and it is looking for 116 volunteers for the current phase.
Official trial title:
A Multi-center, Open, Single-arm, Switch-over, Prospective, Phase IV Study to Assess the Ease of Use, Preference, and Safety After 8 Weeks Subcutaneous Administration of EutropinPen Inj. in Patients Pretreated With Recombinant Human Growth Hormone by Reusable Device